AbSorber
Related
Latest news
-
2010-03-01
AbSorber strengthen its position on the important US market by acquiring NorDiag’s share of Olerup Inc. AbSorber buys the company together with SSP Primers and after the transition will AbSorber own 50 percent of Olerup Inc. and SSP Primers 50 percent. -
2009-12-09
AbSorber receives European patent protection for its transplantation cross match-test XM-ONE® -
2009-07-02
AbSorber AB announced today a new global distribution partner for the transplantation diagnostic product XM-ONE® effective from July 1, 2009. -
2009-05-05
Professor Ron Shapiro, Pittsburgh, PA, discusses the XM-ONE Multicenter Study...
The history of AbSorber AB
AbSorber was founded in 1999 based on inventions made by Associate Professor Jan Holgersson at the Department of Clinical Immunology, and Associate Professor Suchitra Holgersson at the Department of Transplantation Surgery, Karolinska University Hospital, Huddinge, Sweden.
The company initially focused on xenotransplantation, developing techniques for removing antibodies against alpha-Gal as well as for reducing the immunogenicity of neural stem cells that can potentially be used for treating neurological disorders.
Currently, AbSorber has one product on the market, XM-ONE®, a CE marked and FDA registered crossmatchtest for the detection of anti endothelial cell antibodies. A number of products for allogeneic transplantation are under development.